Login to Your Account



JNJ Captures Cougar in $970M Purchase

By Catherine Hollingsworth


Tuesday, May 26, 2009
Johnson & Johnson went a long way toward strengthening its oncology pipeline, agreeing to buy Cougar Biotechnology Inc. in a deal worth just under $1 billion. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription